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O B J E C T I V E S This prospective study aimed to assess regional and temporal patterns of extracel-
lular matrix (ECM) changes post-myocardial infarction (MI).
B A C KG ROUND A fundamental process in the development of ischemic left ventricular (LV)
dysfunction is LV remodeling, characterized by structural and functional abnormalities throughout the
myocardium including the noninfarcted (remote) myocardium and interstitium.
METHOD S Contrast-enhanced cardiac magnetic resonance (CMR) was performed on MI patients
acutely (mean: 5 days post-MI, n  25) and repeated subacutely (mean: 139 days post-MI, n  21), and was
also performed in a separate group of 15 patients with chronic MI (mean: 2,580 days post-MI, n 15). Twenty
volunteers without a history of MI acted as controls. CMR was used to evaluate LV morphology and function,
with post-contrast T1mapping to semiquantitatively assess changes in the ECM. Putativemediators of myocardial
inﬂammation and ﬁbrosis, including macrophage migration inhibitory factor (MIF), were also measured.
R E S U L T S Age, sex, and diabetic and hypertensive status did not differ between MI groups and
controls. Compared with controls, patients early post-acute MI demonstrated reduced LV ejection
fraction (50.25  7.29% vs. 66.7  6.2% [controls], p  0.0001). Myocardium remote to the infarction
early post-acute MI, compared with controls, demonstrated reduced systolic thickening (60  5.0% vs.
106  7.6%, p  0.0002), and lower post-contrast myocardial T1 times suggestive of ECM expansion
(437  113 ms vs. 549  119 ms, p  0.01). In a subgroup analysis between early post-acute MI and
controls of similar age and sex, the remote sector post-contrast myocardial T1 times remained
signiﬁcantly shorter post-acute MI compared with controls (420  121 ms vs. 529  113 ms, p  0.03).
Serum levels of MIF inversely correlated with global myocardial T1 time in patients early post-acute MI
(r  0.6, p  0.01), suggesting a coupling of regional healing with acute LV remodeling.
CONC L U S I O N S Within a week of acute MI, the remote myocardium exhibits systolic dysfunction
and expansion of the ECM, which is coupled with physiological infarct healing. Further prospective
studies with larger sample sizes are needed to verify these important ﬁndings. (J Am Coll Cardiol Img
2012;5:884–93) © 2012 by the American College of Cardiology Foundation
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885fundamental process in the development of
ischemic left ventricular (LV) dysfunction is
LV remodeling, characterized by structural
and functional abnormalities occurring
throughout the myocardium (1). This paradigm of
LV remodeling is based on the concept that struc-
tural changes in the infarct zone result in adverse
LV wall stress in the noninfarct zone, and with
See page 894
time, progressive LV dilation and dysfunction
ensue (2,3). Diffuse myocardial fibrosis, which
represents an important histological hallmark of
end-stage cardiomyopathy in humans (1,4), may
develop in the noninfarcted myocardium early
after acute myocardial infarction (MI) in animals
(5– 8). However, to what extent diffuse myocar-
dial fibrosis contributes to LV remodeling re-
mains uncertain (1,3). The extent of myocardial
fibrosis development following MI has important
prognostic implications because therapy with al-
dosterone receptor antagonists, which possess
antifibrotic properties, improves clinical out-
comes (9 –11).
Gadolinium-based contrast can accumulate
throughout the myocardium when the extracellu-
lar matrix (ECM) is diffusely expanded due to
increased collagen deposition, with prior animal
studies showing a correlation between myocardial
T1 relaxation time and total collagen content
(12). Post-contrast myocardial T1 mapping has
been validated to semiquantitatively detect diffuse
myocardial fibrosis in patients with chronic heart
failure (4), aortic stenosis, and hypertrophic car-
diomyopathy (13). We hypothesized that there
may be acute expansion of the ECM suggestive of
a diffuse fibrotic response post-acute MI in the
noninfarcted (remote) myocardium that may con-
tribute to LV remodeling. We utilized contrast-
enhanced cardiac magnetic resonance (CMR) to
assess LV remodeling in patients post-MI and
measured serum N-terminal propeptides of type I
and III procollagen (PINP and PIIINP, respec-
tively) to evaluate myocardial collagen turnover
(9,11). Putative mediators of myocardial inflam-
mation and fibrosis, including macrophage mi-
gration inhibitory factor (MIF) (14–16) and trans-
forming growth factor-1 (TGF-1) (8,17), were
sampled to explore any association of infarct
healing with regional and global myocardial T1
times.M E T H O D S
CMR with post-contrast myocardial T1 mapping
was performed in 2 groups of participants at varying
time points post-MI (acute, subacute, and chronic)
and in a group of controls without prior MI. All
research was performed at the Alfred Hospital,
Melbourne, Australia, between June 2009 and Jan-
uary 2011 following approval by the Alfred Hospi-
tal Human Research Ethics Committee. All pa-
tients provided informed written consent.
Study participants. EARLY POST-ACUTE MI GROUP.
Consecutive patients 18 years old with first-
presentation ST-segment elevation MI due to
single-vessel coronary occlusion were in-
vited to participate following percutaneous
coronary intervention (PCI). Patients hav-
ing 1 or more of the following criteria
were excluded: an intracardiac device or
metallic prosthesis not compatible with
CMR (e.g., pacemaker); severe claustro-
phobia; and renal impairment (estimated
glomerular filtration rate 60 ml/min).
SUBACUTE MI GROUP. All enrolled pa-
ients post-acute MI were invited to return
or a follow-up CMR examination 3 to 6
onths following their index admission,
orming the subacute MI group.
CHRONIC MI GROUP. A separate group of
patients with prior MI formed the chronic
MI group. These patients either had a his-
tory of single-vessel coronary artery disease
on coronary angiography in a setting of prior
MI 6 months ago or a remote history of
MI without current evidence of ischemia
documented by nuclear perfusion imaging.
CONTROL GROUP. Volunteers with nor-
mal LV systolic function, no structural
heart disease, and no symptoms of heart
failure or MI formed the control group.
CMR protocol. CMR studies were performed on a
linical 1.5-T CMR scanner (Signa HDx 1.5T, GE
ealthcare, Waukesha, Wisconsin). All analyses
ere performed offline using ReportCARD version
.6 (for LV volumetric and infarct size assessment)
nd VizPack Application version 7.3.0 (GE Health-
are, Waukesha, Wisconsin) (for T1 mapping and
egional LV function assessment).
ASSESSMENT OF LV VOLUME AND FUNCTION. In
controls, a bright-blood 2-dimensional steady-state
free precession pulse sequence was employed to
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886ography views (4). In MI patients, LV systolic
function and ejection fraction (LVEF) were calcu-
lated by volumetric analysis (18). Additionally,
separate cine views were acquired in 3 short-axis
slices (basal, midventricular, and apical) for com-
parison with T1 mapping and edema sequences as
escribed in the following text. Regional wall
hickness and systolic thickening assessments
ere performed from the basal, mid, and apical
hort-axis slices by calculating the end-diastolic
nd end-systolic wall thicknesses as well as the
ercentage systolic thickening (19).
MYOCARDIAL EDEMA ASSESSMENT. T2-weighted
short-tau inversion recovery (STIR) fast spin echo
images were acquired in 3 short-axis slices (basal,
midventricular, and apical) to quantify myocardial
edema (20). A relative STIR ratio of2.2 was used
to define the presence of myocardial edema (20).
MI SIZE QUANTIFICATION. Late gadolinium en-
ancement (LGE) imaging was performed 10 to 15
in after a bolus of gadolinium–diethylenetriamine
entaacetic acid (DTPA) (0.2 mmol/kg, Magnev-
st, Bayer Schering Pharma, Leverkusen, Germany)
sing an inversion recovery gradient echo technique
n the LV short-axis stack as for volumetric anal-
Figure 1. Myocardial Sectoring and T1 Mapping
Myocardial sectoring was performed by subdividing each of the 3 s
cumferential sectors (with 60° arc). Only T1 maps with an R-squared
T1 time was calculated for each myocardial sector. LGE  late gado
SA  short-axis.sis. The area of hyperenhanced myocardium
bounded by endocardial and epicardial contours) on
ach of the short-axis slices was manually traced, and
hen multiplied by the slice thickness and the myo-
ardial density of 1.05 g/ml to obtain the infarct mass.
POST-CONTRAST MYOCARDIAL T1 MAPPING. T1
mapping was performed on a set of 10 images
obtained by employing varying inversion times (75
to 750 ms) acquired 15 to 20 min after bolus
gadolinium-DTPA using an inversion recovery–
prepared fast gradient echo sequence at the basal,
midventricular, and apical short-axis views (4).
These images were then processed with a curve-
fitting technique to generate T1 maps using a
dedicated research software package (Fig. 1). Only
T1 maps with an R-squared value for the curve fit
of 0.95 were used in the analysis.
MYOCARDIAL SECTORING FOR EDEMA, INFARCT, T1
MAPPING, AND REGIONAL SYSTOLIC THICKENING
ASSESSMENT. In all patients, we subdivided each of
he 3 short-axis LGE slices into 6 equal circumfer-
ntial sectors (with 60° arc) (Fig. 1) to generate 18
yocardial sectors (MS) per patient (21). We
efined MS1 as the point of right ventricular
nsertion into the LV at end-diastole. A sector with
t-axis (mid-LV shown in this schema) LGE slices into 6 equal cir-
lue for the curve ﬁt of 0.95 were used in the analysis. A speciﬁc
m enhancement; LV  left ventricle; MS  myocardial sector;hor
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887LGE visible in 50% of the arc of the sector (i.e.,
30°) was defined as an infarct sector, whereas a
peri-infarct sector was defined as having any LGE
within the sector. A remote sector was defined as
any sector with no LGE. Myocardial sectoring was
then applied in the same fashion to cine, STIR, and
T1 images. In some patients without anterior or
anteroseptal infarction, MS1 and MS2 appeared
bright because of flow artifact created by the LV
outflow tract. These sectors were excluded from all
analyses. Areas of extensive microvascular obstruc-
tion were also excluded from T1 mapping analysis.
Biochemical analysis. All routine biochemistries
ere analyzed by the Alfred Hospital Pathology
ervice. TGF-1 was measured in sera in duplicates
sing enzyme-linked immunosorbent assay (Life
esearch, Scoresby, Victoria, Australia). MIF was
easured in plasma in duplicates by enzyme-linked
mmunosorbent assay (DuoSet human MIF, cat#
Y289, R&D Systems, Minneapolis, Minnesota)
14). PINP was determined by electrochemilumi-
escence immunoassay using a commercially avail-
ble radioimmunoassay kit (Cobas, Roche Diag-
ostics, Basel, Switzerland). PIIINP measurements
ere performed using a commercially available ra-
ioimmunoassay kit (UniQ, Orion Diagnostica,
spoo, Finland). Serum N-terminal pro–B-type
atriuretic peptide (NT-proBNP) concentration
as determined using electrochemiluminescence
Table 1. Baseline Characteristics
Control (n  20)
Age, yrs 54.7 10.2
Age of infarct, days NA
Male 13 (65%)
Hypertension 8 (40%)
Current smoking 0 (0%)
Diabetes 0 (0%)
Body mass index, kg/m2 27.0 4.2
Anterior MI NA
Heart rate, beats/min 66 16
eGFR, ml/min 97.0 39.5
Medications
Aspirin 0 (0%)
Angiotensin-converting enzyme inhibitors 6 (30%)
Angiotensin-receptor blockers 1 (5%)
Aldosterone-receptor antagonists 0 (0%)
Beta-blocker 4 (20%)
Statins 0 (0%)
Primary PCI NA
Values are n (%) or mean  SD, or median [interquartile range]. p values in b
chronic MI.
eGFR  estimated glomerular ﬁltration rate; MI  myocardial infarction; PCI  pemmunoassay on the Roche E170 analyzer (Roche
iagnostics).
Statistical analysis. Continuous, normally distrib-
uted data were expressed as mean  SD, and
categorical variables were presented as counts and
percentages. Sample size calculation was based on
our prior study that demonstrated that controls
had a myocardial T1 time of 564  103 ms (4).
Thus, based on an expected difference in T1 time
of 20%, and using a standard deviation of 103 ms,
we calculated that a sample size of 15 per group
would be required to achieve a desired power of
0.80 with an alpha value of 0.05. Continuous
variables were compared with either paired or
unpaired Student t tests, or 1-way analysis of
variance with Bonferroni correction. Categorical
variables were compared between groups with a
chi-square or Fisher exact test where appropriate.
Correlation between continuous parameters was
assessed with Pearson’s product-moment correla-
tion coefficient. A subgroup analysis between
early post-acute MI and control participants of
similar age and sex was performed to examine
differences in myocardial T1 time in the remote
myocardium. Values of p  0.05 were considered
statistically significant. All analyses were per-
formed with SPSS version 16 (SPSS Inc., Chi-
cago, Illinois).
ly Post-Acute MI (n  25) Chronic MI (n  15) p Value
58.6 8.8 59.4 12.8 NS
4.8 4.7 2,580.3 2,472.5
3.5 [3–5.5] 2,366 [259–4,444]
20 (88%) 12 (80%) NS
8 (32%) 7 (47%) NS
12 (48%) 4 (27%) 0.001*†
3 (12%) 2 (13%) NS
26.7 3.0 28.7 2.9 NS
10 (40%) 10 (67%) NS
69 8 62 8 NS
95.1 26.9 77.8 21.3 NS
25 (100%) 14 (93%) <0.001*†
21 (84%) 12 (80%) <0.0001*†
2 (8%) 1 (7%) NS
4 (16%) 2 (13%) NS
22 (88%) 13 (87%) <0.0001*†
23 (92%) 14 (93%) <0.0001*†
25 (100%) 8 (53%) NS
are statistically signiﬁcant. *Control versus early post-acute MI; †control versusEar
oldrcutaneous coronary intervention; NS  not signiﬁcant.
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888R E S U L T S
Clinical and demographic data. A total of 60 patients
were enrolled, with 25 patients in the early post-
acute MI group, 15 patients in the chronic MI
group, and 20 controls (Table 1). We performed
repeat CMR and biomarker evaluation in 21 of 25
early post-acute MI patients, which formed the
subacute MI group. Age, sex, body mass index,
diabetic status, and hypertensive status were similar
across all groups (p  NS). The mean infarct age
was 4.8  4.7 days, 139.2  54.7 days, and 2,580.3 
2,472.5 days in the early post-acute, subacute, and
chronic MI groups, respectively. All early post-
acute (and subacute) MI patients underwent pri-
mary PCI, whereas only one-half of the chronic MI
group were reperfused by primary PCI (100% vs. 53%,
p  0.09). Heart rate and renal function were not
different across all 3 groups (Table 1).
LV volume, function, and infarct characteristics. Pa-
tients early post-acute MI had greater infarct mass
and infarct size compared with the chronic MI
group (Table 2). There was an increase between
control, early post-acute MI, and chronic MI
groups with respect to indexed LV end-systolic
volume (all p  0.01) and between control and
chronic MI LV end-diastolic volume (p  0.01).
LVEF was lowest among patients early post-acute
MI and highest in controls (50.2 7.3% vs. 66.6
6.2%, p  0.0001). Compared with controls, both
Table 2. LV Volume, Function, and Infarct Characteristics by CM
Control E
Body surface area, m2 1.9 0.3
LV mass indexed, g/m2 60.6 15.4
Delayed enhancement, g NA
Myocardial infarct size, % NA
LVEF, % 66.6 6.2
LVEDVi, ml/m2 77.0 16.9
LVESVi, ml/m2 26.7 9.3
Infarct ESWT, mm NA
Infarct EDWT, mm NA
Infarct ESWT, % NA
Peri-infarct ESWT, mm NA
Peri-infarct EDWT, mm NA
Peri-infarct ESWT, % NA
Remote ESWT, mm 9.9 2.0
Remote EDWT, mm 5.2 1.3
Remote ESWT, % 105.6 34.1
Values are mean  SD. p values in bold are statistically signiﬁcant. *Contro
chronic MI.
CMR  cardiac magnetic resonance; EDWT  end-diastolic wall thickness; ESW
LV  left ventricular; LVEDVi  left ventricular end-diastolic volume index; LVE
index; NA  not applicable; other abbreviations as in Table 1.early post-acute and chronic MI groups demon-
strated a reduction in regional systolic thickening in
the remote sectors (acute: 59.6  24.6%, chronic:
68.4 32.6%, control: 105.6 34.1%, p  0.002),
consistent with remodeling of the remote (nonin-
farcted) myocardium (Table 2). CMR examination
in subacute MI patients demonstrated persistence
of changes identified acutely with respect to in-
creased LV volumes (90.3  26.0 ml/m2 vs. 85.8 
16.5 ml/m2, p  NS) and reduced regional systolic
function in infarct (65.0 36.5% vs. 57.5 31.9%,
p  NS), peri-infarct (70.8  38.2% vs. 55.8 
23.0%, pNS), and remote regions (67.0 27.9%
vs. 59.6  24.6%, p  NS) (Table 3).
Post-contrast myocardial T1 times. Post-contrast
myocardial T1 times were reduced in the infarct
sectors compared with controls in both early post-
acute and chronic MI groups (319  64 ms vs.
549  119 ms and 323  65 ms vs. 549  119 ms,
espectively, all p  0.0001) (Fig. 2). Peri-infarct
ector post-contrast T1 times were significantly
horter in patients early post-acute MI compared
ith controls. Additionally, remote post-contrast
1 times in early post-acute MI patients were also
ignificantly shorter than controls (437  113 ms
s. 549  119 ms, p  0.01), suggestive of ECM
xpansion in these regions. There was a strong
rend to shorter post-contrast T1 times in remote
ectors of chronic MI patients compared with
ontrols (464  117 ms vs. 549  119 ms, p 
Post-Acute MI Chronic MI p Value
2.0 0.2 2.0 0.2 NS
74.0 13.8 64.6 13.8 0.01*
28.6 18.6 16.0 7.6 0.03‡
19.2 10.5 12.73 5.0 0.05‡
50.2 7.3 51.2 12.7 <0.0001*†
85.8 16.5 97.3 24.6 0.01†
42.9 12.7 50.1 27.3 <0.01*†
8.4 1.5 8.1 2.3 NS
5.6 1.2 5.3 1.2 NS
57.5 31.9 62.8 46.2 NS
8.4 1.4 9.3 2.9 NS
5.6 0.8 5.4 1.3 NS
55.8 23.0 80.1 37.5 0.02‡
8.8 1.3 8.6 2.6 NS
5.8 1.1 5.2 0.9 NS
59.6 24.6 68.4 32.6 <0.002*†
sus early post-acute MI; †control versus chronic MI; ‡early post-acute versus
end-systolic wall thickness; ESWT%  percentage end-systolic wall thickening;
left ventricular ejection fraction; LVESVi  left ventricular end-systolic volumeR
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8890.07). Similarly, global myocardial T1 times were
shorter in early post-acute and chronic MI patients
compared with controls (all p  0.005). Compared
ith early post-acute MI patients, post-contrast T1
imes were increased in the subacute MI group in
eri-infarct (395  62 ms vs. 446  74 ms, p 
.04) and remote sectors (434 93 ms vs. 515 68
s, p  0.01) (Table 3).
To exclude age and sex as confounding variables for
yocardial T1 time changes in remote regions, we
erformed a separate subgroup analysis in 15 early
ost-acute MI and 11 control participants of similar
ge and sex in which remote post-contrast myocardial
1 times remained significantly shorter post-acute MI
ompared with controls (420 121 ms vs. 529 11 3
s, p  0.03). There were no significant differences in
he mean heart rate between control and MI groups
efore CMR examination (control: 66  16 beats/min,
arly post-acute MI: 69 8 beats/min, chronic: 62 8
eats/min, all p  0.05), excluding heart rate as a
onfounding factor in the measurement of myocardial
1 time (4). Furthermore, the remote myocardial T1
imes in the early post-acute MI group were not different
mong patients who were diabetic versus nondiabetic
atients, and smokers versus nonsmokers (pNS for all
comparisons).
Significant positive correlations were observed
between early post-acute and subacute MI mean
global T1 times with LVEF (r 0.4, p 0.05; and
 0.5, p  0.03, respectively). There was also a
ositive correlation between chronic MI global T1
ime and LVEF (r  0.5, p  0.06).
A small number of MS could not be analyzed due
o artifact, microvascular obstruction, or poor curve
t (early post-acute MI: 74 of 450  16%; subacute
I: 19 of 378 5%; chronic MI: 25 of 270 9%).
Myocardial edema. The mean infarct STIR ratio
as elevated early post-acute MI compared with
hronic MI (3.0  0.4 vs. 1.9  0.2, p  0.0001)
nd subacute MI patients (3.0  0.4 vs. 2.1  0.3,
 0.0001). Mean peri-infarct STIR ratio was also
levated early post-acute MI, compared with both
ubacute and chronic MI patients (2.5  0.4 vs.
.1  0.2, and 2.5  0.4 vs. 1.9  0.2, respectively,
ll p  0.005). In remote sectors, however, the
TIR ratio was similar in the early post-acute,
hronic MI, and control groups (2.1  0.2 vs.
.0  0.3 vs. 1.9  0.1, p  NS) and early
ost-acute and subacute MI patients (2.1  0.2
s. 2.0  0.2, p  NS).
MIF and TGF-1. The median [interquartile range]
ampling times for MIF, TGF-1, collagen mark-
rs, and NT-proBNP were 2.5 [1.7 to 4.5] days,46.5 [99 to 181.5] days, and 2,366 [262 to 4,334]
ays for the post-acute, subacute, and chronic MI
roups, respectively. MIF levels were significantly
levated in the early post-acute MI group compared
ith the subacute MI group (Fig. 3A). There was an
nverse correlation between early post-acute MI MIF
evels and mean global T1 time (r0.6, p 0.01)
Fig. 3B). TGF-1 levels were highest among early
post-acute and chronic MI patients, but levels did not
differ significantly between groups (Fig. 3C).
Serum collagen markers and NT-proBNP. No differ-
nce in PINP or PIIINP levels was observed across MI
roups (Figs. 3D and 3E). However, Ln NT-proBNP
as highest early post-acute MI (Fig. 3F). Global post-
ontrast myocardial T1 times correlated inversely with
n NT-proBNP (r  0.5, p  0.02).
D I S C U S S I O N
This prospective study provides evidence of an acute
remodeling response in the remote noninfarcted
myocardium early following acute MI as evidenced
by reduced systolic function in this region. The
demonstration of shortened post-contrast myocardial
Table 3. LV Volume, Function, and Infarct Characteristics by CM
Between Early Post-Acute and Subacute MI Groups
Early Post-Acute MI Subacute MI
LV mass indexed, g/m2 74.0 13.8 65.4 15.8
Delayed enhancement, g 28.6 18.6 16.6 8.0
Myocardial infarct size, % 19.2 10.5 12.8 5.6
LVEF, % 50.2 7.3 52.8 9.4
LVEDVi, ml/m2 85.8 16.5 90.3 26.0
LVESVi, ml/m2 42.9 12.7 43.9 22.0
Infarct ESWT, mm 8.4 1.5 8.4 1.9
Infarct EDWT, mm 5.6 1.2 5.2 0.8
Infarct ESWT, % 57.5 31.9 65.0 36.5
Peri-infarct ESWT, mm 8.4 1.4 8.1 1.6
Peri-infarct EDWT, mm 5.6 0.8 5.0 1.0
Peri-infarct ESWT, % 55.8 23.0 70.8 38.2
Remote ESWT, mm 8.8 1.3 8.3 1.4
Remote EDWT, mm 5.8 1.1 5.3 0.9
Remote ESWT, % 59.6 24.6 67.0 27.9
Infarct STIR 3.0 0.4 2.1 0.3
Peri-infarct STIR 2.5 0.3 2.1 0.2
Remote STIR 2.1 0.2 2.0 0.2
Global STIR 2.4 0.3 2.0 0.2
Mean infarct T1 time 320 69 349 71
Mean peri-infarct T1 time 395 62 446 74
Mean remote T1 time 434 93 515 68
Mean global T1 time 391 75 464 59
Values are mean  SD. p values in bold are statistically signiﬁcant.
STIR  short-tau inversion recovery; other abbreviations as in Tables 1 and 2.R
p Value
0.001
0.002
0.001
0.01
NS
NS
NS
NS
NS
NS
0.03
NS
NS
NS
NS
<0.0001
0.005
NS
0.001
NS
0.04
0.01
0.002T1 times in the remote myocardium is consistent with
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890ECM expansion due to interstitial changes suggestive
of diffuse fibrosis, which is the histological hallmark of
other more chronic forms of heart disease (4,13), with
the absence of myocardial edema making a primary
inflammatory or necrotic response in the noninfarcted
myocardium less likely.
Such acute structural alterations in the remote
myocardium may represent an additional mechanism
to that of the traditional paradigm of LV remodeling
post-MI due to the presence of an infarct scar and
altered LV pressure and volume leading to progressive
LV dilation and dysfunction (2). This complementary
paradigm suggests that there are primary changes in
the ECM that occur acutely in the noninfarct zone
that also contribute to LV remodeling (3). In an
experimental MI mouse model, Tsuda et al. (8)
emonstrated that small infarcts without mechanical
verload stimulated myocardial fibrosis development
n the nonischemic myocardium distant from the
nfarct site as early as 72 h. However, the time course
f acute changes and remodeling in the noninfarct
one in humans is not well understood, in part due to
prior lack of an in vivo imaging modality that could
etect ECM expansion and quantify diffuse fibrosis.
Using CMR, we systematically characterized the
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Figure 2. Post-Contrast T1 Times by Region
Data are presented as mean  SD. (A) Mean infarct, (B) mean peri-infa
the control, early post-acute MI, and chronic MI groups. The mean glo
remote sectors for a patient. *Control versus early post-acute MI; †convolution of LV remodeling and structural alterationsin both infarcted and noninfarcted myocardium post-
MI. Consistent with published data, we found an
increase in indexed LV end-diastolic and end-systolic
volumes with increasing chronicity of infarction
(1,22). In the remote zones, we observed impaired
regional systolic function as well as a profound short-
ening of post-contrast myocardial T1 times among
early post-acute MI patients imaged within a week
post-MI. In a subgroup analysis between early post-
acute MI and control participants with similar age and
sex, the remote post-contrast myocardial T1 times
remained significantly shorter post-acute MI com-
pared with controls. The prevalence of hypertensive
status was also not different between controls and MI
groups. Furthermore, we examined the possibility that
the presence of acute interstitial edema may have also
altered T1 times. However, we demonstrated that
there was no difference in STIR ratio in the remote
sectors of any MI groups compared with controls. A
recent study utilizing T2 mapping also supports the
absence of edema in the remote zone (23). Finally,
variations in heart rate and renal function may affect
myocardial T1 time (4); however, in this study, mean
heart rate and renal function did not differ between
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891Our data suggest that expansion of the ECM
occurs early (within a week) in the noninfarct zone
and persists into chronic stages. The exact nature of
these early interstitial changes in the remote myo-
cardium remains to be characterized. Prior animal
studies support the presence of collagen in the
non-infarct zone within the first few days after
experimental MI (5,6,8). However, no studies in
humans have characterized the evolution of struc-
tural alterations in both infarcted and noninfarcted
myocardium and systolic dysfunction after MI. The
observation of a partial recovery of remote T1 time
in the subacute MI stage, but a strong trend toward
shortening of remote T1 times in the chronic stage
compared with controls suggests that early intersti-
tial changes in the remote myocardium may partially
regress and is consistent with data suggesting that
interstitial fibrosis may be a reversible process (24),
particularly with modulation of the renin-angiotensin-
aldosterone axis (9,11,25) early post-MI.
The mechanisms that mediate the acute ECM
changes throughout the noninfarct zone are ill
defined and may involve myofibroblasts activated
during the early inflammatory phase migrating out
of the wound area, or neurohumoral factors (ang-
iotensin II and TGF-1) activating fibroblasts that
are resident in the remote sites (26,27). For this
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N-terminal pro–B-type natriuretic peptide; MIF  macrophage migr
lagen; PINP  N-terminal propeptide of type I procollagen; TGF-1 reason, we sought to determine whether there was ean association between the ECM changes identified
by T1 mapping and putative mediators of myocar-
dial inflammation and fibrosis. MIF is a pleiotropic
cytokine that regulates a broad spectrum of acute
and chronic inflammatory responses (28) and is
thought to be released from preformed cytoplasmic
myocyte stores early after MI (14,16). Myocardial
MIF release may be one of the earliest secreted
inflammatory mediators to be detected as a conse-
quence of macrophage activation (16). MIF medi-
ates ongoing inflammation by promoting produc-
tion of other proinflammatory cytokines by
macrophages (e.g., interleukin-1, TNF-) (15) and
s critical in the recruitment of macrophages and T
ells into the infarcted myocardium (16), which
hen facilitates healing by scar formation. Our
nding of an inverse correlation between serum
IF levels and mean global T1 time early post-
cute MI suggests that there is biological coupling
f the intense inflammatory response post-MI with
evelopment of ECM expansion and interstitial
lterations in both the infarcted and noninfarcted
yocardium. Similar to MIF, TGF-1 levels, a
ell-known fibrogenic cytokine (17), trended
igher in the acute than the subacute stages. How-
ver, we did not observe any correlations between
egional post-contrast T1 times and TGF-1 lev-
p < 0.04*†
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892sample size, the varied sampling time points post-
acute MI, and that the systemic sampling of TGF-
1, in contrast to MIF sampling, may not detect a
significant local or paracrine (myocardial) effect. Al-
though we were not able to detect any significant
differences in either PINP or PIIINP levels between
the MI groups, Ln NT-proBNP was highest early
post-acute MI and again correlated inversely with
global post-contrast myocardial T1 times, suggesting
that changes in the ECM are associated with a less
compliant LV, which leads to higher NT-proBNP
levels. It is possible that myocardial T1 mapping might
be a more sensitive method for evaluation of ECM
changes than systemic sampling of collagen markers
because T1 mapping directly assesses myocardial tissue
composition compared with systemic biomarkers, which
are subject to many influences, including the timing
post-MI and location of sampling. However, direct
comparisons between T1 mapping and collagen markers
have not yet been performed.
Study limitations. This was a small prospective study
in highly selected groups of patients post-MI.
Although we performed a subgroup analysis be-
tween early post-acute MI and controls of similar
age and sex, and also found no differences in heart
rate and renal function between MI groups and
controls, there could be confounding effects from
the heterogeneity within the MI groups with re-
spect to MI location, medication use, and the
success of recanalization in the chronic MI group
that might impact MI size, rate of healing, and
myocardial T1 times. Although age, sex, and dia-
betic and hypertensive status did not differ between
MI groups and controls, it is possible that some
confounding effect may be missed due to the small
sample size. Similarly, the small sample size might
have meant that the study was underpowered to
detect a difference in collagen biomarkers. Addi-
tionally, some of the controls were also on antihy-
pertensive therapy, which might have affected myo-
cardial T1 time because of the antifibrotic1161–72. 1574–80.perform CMR within the first 2 days following
infarction in the majority of the patients in the early
post-acute MI group, and therefore, we are unable
to provide data on the dynamic process of necrosis
and infarct expansion within this early time frame.
Another limitation of this study is the lack of
histological data immediately after infarction to
correlate ECM changes with noninfarct zone (re-
mote) T1 time changes; however, several studies
have now validated T1 mapping with histology
(4,12,13). It is also possible that some selection bias
was present in recruitment of chronic MI patients
because many patients with LVEF 35% would
have had cardioverter-defibrillator implantation and
precluded CMR assessment. Finally, only 47% of
chronic MI patients had angiographic assessment
within 12 months of the study. However, the
remainder all had recent nuclear myocardial perfu-
sion stress testing to exclude ischemia.
C O N C L U S I O N S
This study suggests that physiological healing in
acute MI is coupled with early remodeling and
ECM expansion in the remote myocardium that
persist into chronic stages, driven by the inflamma-
tory response post-MI, mediated in part by MIF.
The extent of ECM change correlates significantly
with global and regional systolic dysfunction and
has important prognostic implications because phar-
macological modulation of the renin-angiotensin-
aldosterone axis appears to limit ECM turnover in
the remote myocardium during all stages of MI
healing (10,29,30). Further prospective studies with
larger sample sizes are needed to verify these im-
portant findings.
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